EVALUATE THE SURGICAL RESULTS OF TRANSORAL ENDOSCOPIC THYROIDECTOMY (TOETVA) TREATED DIFFERENTIATED THYROID CANCER IN MALES

Thế Đường Lê, Quốc Duy Ngô, Đức Toàn Trần, Xuân Quý Ngô, Văn Quảng Lê

Main Article Content

Abstract

Objects: Thyroid cancer in males exhibits some differences compared to females, such as larger tumor size and higher rates of lymph node metastasis. These characteristics impact both diagnosis and treatment outcomes. Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) has gained popularity worldwide, offering several advantages in cancer surgery. However, there is currently no research assessing the effectiveness of this method in male patients. Patients and Methods: The study included 32 male patients diagnosed with differentiated thyroid cancer who underwent endoscopic surgery using the TOETVA method at Vietnam National Cancer Hospital from December 2018 to December 2023. Results: The average age was 25.6 ± 5.7 years (16 - 35 years). The average tumor size was 9.0 ± 3.4 mm (4 - 18 mm). 29 patients had single thyroid lobe removed along with the isthmus and central neck dissection with an average surgery time of 92.6 ± 3.4 minutes. Only 3 patients had total thyroidectomy and central cervical lymph node dissection with an average surgery time of 130.4 ± 2.3 minutes. The rate of central neck lymph node metastasis after surgery is 53.1%. Complications were rare, mostly temporary, and resolved within 3 months. The average postoperative recovery time was 4.2 ± 1.3 days (2 - 9 days). All patients experienced mild postoperative pain and were satisfied with the aesthetic results. Conclusion: TOETVA is a safe and effective method that achieves optimal aesthetic results in male patients with differentiated thyroid cancer.

Article Details

References

1. Sung H., Ferlay J., Siegel R.L., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 71(3), 209–249.
2. Gajowiec A., Chromik A., Furga K., et al. (2021). Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?. J Clin Med, 10(11), 2438.
3. Kim M.J., Lee S.G., Kim K., et al. (2019). Current trends in the features of male thyroid cancer: Retrospective evaluation of their prognostic value. Medicine (Baltimore), 98(19), e15559.
4. Russell J.O., Sahli Z.T., Shaear M., et al. (2020). Transoral thyroid and parathyroid surgery via the vestibular approach—a 2020 update. Gland Surg, 9(2), 409–416.
5. Anuwong A. (2016). Transoral Endoscopic Thyroidectomy Vestibular Approach: A Series of the First 60 Human Cases. World J Surg, 40(3), 491–497.
6. Le Q.V., Ngo D.Q., Tran T.D., et al. (2020). Transoral Endoscopic Thyroidectomy Vestibular Approach: An Initial Experience in Vietnam. Surg Laparosc Endosc Percutan Tech, 30(3), 209–213.
7. Anuwong A., Ketwong K., Jitpratoom P., et al. (2018). Safety and Outcomes of the Transoral Endoscopic Thyroidectomy Vestibular Approach. JAMA Surg, 153(1), 21–27.
8. Nguyen H.X., Nguyen H.X., Nguyen T.T.P., et al. (2022). Transoral endoscopic thyroidectomy by vestibular approach in Viet Nam: surgical outcomes and long-term follow-up. Surg Endosc, 36(6), 4248–4254.
9. Wang Y., Zhou S., Liu X., et al. (2021). Transoral endoscopic thyroidectomy vestibular approach vs conventional open thyroidectomy: Meta-analysis. Head Neck, 43(1), 345–353.
10. Wang T., Wu Y., Xie Q., et al. (2020). Safety of central compartment neck dissection for transoral endoscopic thyroid surgery in papillary thyroid carcinoma. Jpn J Clin Oncol, 50(4), 387–391.